ZAGG, Inc. (NASDAQ: ZAGG) 14.5% HIGHER; released updated financial guidance for fiscal year 2014. The Company stated that net sales are forecast to be in a range of $250 – $255 million from a previous range of $225 – $235 million, with corporate gross margin in the low 30’s versus the previously forecast of high 20’s, and Adjusted EBITDA in a range of $30 – $32 million versus the previous forecast of $15 – $20 million. *** The Street sees FY14 revs of $232.5 million.
Tetraphase Pharma (Nasdaq: TTPH) 14.5% HIGHER; announced